Sanofi top pharmaceuticals revenue change 2020

Published by Matej Mikulic, Mar 8, 2021
This statistic shows the change in revenue of Sanofi's top pharmaceuticals in 2020 compared to the previous year. Dupixent, a rare blood disorder drug, showed the highest growth rate among all of Sanofi's best-selling pharmaceutical drugs.

Change in revenue of Sanofi's top pharmaceuticals in 2020 compared to previous year*

Loading statistic...

© Statista 2021
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2021

Region

Worldwide

Survey time period

2019 and 2020

Supplementary notes

* Change measured on a reported basis.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical biotech industry"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical Industry in Denmark Pharmaceutical industry in the UKPharmaceutical market in Italy
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu